EUVIMEDEUVIMED entdecken
Leitlinie

ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome

Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain, Corey Cutler, Joan Guitart, Youn H Kim, Larisa J Geskin, Richard T Hoppe, Lynn D Wilson, Anne W Beaven und 29 weitere

Journal of the American Academy of Dermatology · 2025-08 · 93 (2) · 387-397

DOI: 10.1016/j.jaad.2025.04.005 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the American Academy of Dermatology, 2025-08. Verfasst von Amrita Goyal und 40 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Minnesota, Minneapolis, Minnesota. Electronic address: goyal046@umn.edu. Hauptthemen laut MEDLINE: Mycosis Fungoides, Sezary Syndrome, Skin Neoplasms, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma. While MF generally follows an indolent course, a subset of patients will experience progressive and/or treatment-refractory disease. SS is an aggressive cutaneous T-cell lymphoma associated with high morbidity and mortality secondary to immune compromise and opportunistic infection. Although allogeneic hematopoietic cell transplant (allo-HCT) is currently the only available potentially curative treatment modality for MF/SS and is included in the National Comprehensive Cancer Network and the American Society for Transplantation and Cellular Therapy treatment guidelines, there is no published guidance regarding referral criteria, timing and allo-HCT approach to help guide clinicians caring for these patients. METHODS: Delphi survey of 32 specialists in dermatology (n = 9), transplant hematology/oncology (n = 10), nontransplant hematology/oncology (n = 8), and radiation oncology (n = 5) from across the United States. Consensus required agreement of ≥75% of participants. RESULTS: Sixteen consensus statements were generated on 4 topics: 1) criteria for referral for consideration for allo-HCT, 2) allo-HCT preparative regimens and procedures, 3) disease status at the time of allo-HCT, and 4) multidisciplinary management in the pre- and post-transplant settings. CONCLUSION: These clinical practice guidelines provide a framework for decision-making regarding allo-HCT for MF/SS and highlight areas for future prospective investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycosis FungoidesSezary SyndromeSkin NeoplasmsHematopoietic Stem Cell TransplantationHumansTransplantation, HomologousDelphi TechniqueConsensusUnited StatesTransplantation ConditioningReferral and Consultation

Stichwörter der Autor:innen

Sezary syndromeTSEBTallogeneicallogeneic stem cell transplantconditioningcutaneous T-cell lymphomadermatologygraft-versus-hosthematology/oncologyhematopoietic stem cell transplantmatched related donormatched unrelated donormycosis fungoidesmyeloablativeradiation oncology

Autor:innen und Institutionen

  • Department of Dermatology, University of Minnesota, Minneapolis, Minnesota. Electronic address: goyal046@umn.edu.
  • Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota.
  • Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Blood and Marrow Transplantation, and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California.
  • Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.
  • Division of Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.

Förderung

  • NCI NIH HHS

Zitieren

APA

Goyal, A., O'Leary, D., Dabaja, B., Weng, W. K., Zain, J., Cutler, C., Guitart, J., Kim, Y. H., Geskin, L. J., Hoppe, R. T., Wilson, L. D., Beaven, A. W., Horwitz, S., Allen, P. B., Barta, S. K., Bohjanen, K., Brammer, J. E., Carter, J. B., Comfere, N., …, & Foss, F. (2025). ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome. Journal of the American Academy of Dermatology, 93(2), 387-397. https://doi.org/10.1016/j.jaad.2025.04.005

Vancouver

Goyal A, O'Leary D, Dabaja B, Weng WK, Zain J, Cutler C, et al. ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome. Journal of the American Academy of Dermatology. 2025;93(2):387-397. doi:10.1016/j.jaad.2025.04.005

BibTeX
@article{Goyal2025,
  author = {Goyal, Amrita and O'Leary, Daniel and Dabaja, Bouthaina and Weng, Wen-Kai and Zain, Jasmine and Cutler, Corey and Guitart, Joan and Kim, Youn H and Geskin, Larisa J and Hoppe, Richard T and Wilson, Lynn D and Beaven, Anne W and Horwitz, Steve and Allen, Pamela B and Barta, Stefan K and Bohjanen, Kimberly and Brammer, Jonathan E and Carter, Joi B and Comfere, Nneka and DeSimone, Jennifer A and Dusenbery, Kathryn and Duvic, Madeleine and Huen, Auris and Jagadeesh, Deepa and Kelsey, Chris R and Khodadoust, Michael S and Lechowicz, Mary Jo and Mehta-Shah, Neha and Moskowitz, Alison J and Olsen, Elise A and Poh, Christina and Pro, Barbara and Querfeld, Christiane and Sauter, Craig and Sokol, Lubomir and Sokumbi, Olayemi and Wilcox, Ryan A and Zic, John A and Gru, Alejandro and Hamadani, Mehdi and Foss, Francine},
  title = {ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome},
  journal = {Journal of the American Academy of Dermatology},
  year = {2025},
  volume = {93},
  number = {2},
  pages = {387--397},
  doi = {10.1016/j.jaad.2025.04.005}
}
Kostenlos starten →